Localized scleroderma and related comorbidities: a single centre cohort study
Br J Dermatol. 2025 Oct 27:ljaf419. doi: 10.1093/bjd/ljaf419. Online ahead of print. ABSTRACT BACKGROUND: Localized scleroderma, or morphea is a […]
PubMed
PubMed
The Enigma of Paradoxical Reactions to Biological Therapies
Indian Dermatol Online J. 2025 Oct 27. doi: 10.4103/idoj.idoj_1115_24. Online ahead of print. ABSTRACT The advent of targeted biological agents
PubMed
A case of disseminated and chronic varicella zoster virus infection with persistent ulcer formation in a rheumatoid vasculitis patient treated with immunosuppressants
JAAD Case Rep. 2025 Sep 8;65:153-156. doi: 10.1016/j.jdcr.2025.06.064. eCollection 2025 Nov. NO ABSTRACT PMID:41143223 | PMC:PMC12547931 | DOI:10.1016/j.jdcr.2025.06.064
PubMed
Exacerbation of bullous systemic lupus erythematosus with erythema gyratum repens-like pattern following dupilumab
JAAD Case Rep. 2025 Aug 29;65:206-210. doi: 10.1016/j.jdcr.2025.08.020. eCollection 2025 Nov. NO ABSTRACT PMID:41143219 | PMC:PMC12552150 | DOI:10.1016/j.jdcr.2025.08.020
PubMed
Medical guidelines for fibrodysplasia ossificans progressiva
JBMR Plus. 2025 Sep 19;9(11):ziaf150. doi: 10.1093/jbmrpl/ziaf150. eCollection 2025 Nov. ABSTRACT Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic condition
PubMed
A semi-automated ASC speck assay to evaluate pyrin inflammasome activation
Clin Transl Immunology. 2025 Oct 23;14(10):e70054. doi: 10.1002/cti2.70054. eCollection 2025. ABSTRACT OBJECTIVE: To develop a rapid functional assay to validate
PubMed
Ultra-processed food intake is associated with increased gastrointestinal tract symptoms and alterations in gut microbiota in patients with systemic sclerosis
Front Immunol. 2025 Oct 9;16:1610360. doi: 10.3389/fimmu.2025.1610360. eCollection 2025. ABSTRACT BACKGROUND: Alterations in the gastrointestinal (GI) microbiome (i.e., dysbiosis) are
PubMed
Mass spectrometry-based analysis of rheumatoid factor
Front Immunol. 2025 Oct 10;16:1644334. doi: 10.3389/fimmu.2025.1644334. eCollection 2025. ABSTRACT INTRODUCTION: Rheumatoid factor (RF) are autoantibodies that are found in
PubMed
On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information
Front Immunol. 2025 Oct 9;16:1599143. doi: 10.3389/fimmu.2025.1599143. eCollection 2025. ABSTRACT BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is associated with high
PubMed
Multifragmentary proximal humeral fractures-precise fracture anatomy of the tuberosities identified with three-dimensional computed tomography
JSES Rev Rep Tech. 2025 Sep 17;6(1):100585. doi: 10.1016/j.xrrt.2025.09.004. eCollection 2026 Feb. ABSTRACT BACKGROUND: Although the Neer classification of proximal
PubMed
Cardiac disease in systemic sclerosis: a narrative review
Arch Med Sci Atheroscler Dis. 2025 Sep 15;10:e121-e138. doi: 10.5114/amsad/209030. eCollection 2025. ABSTRACT Systemic sclerosis (SSc) is an autoimmune disorder
PubMed
Maternal circulating GPIHBP1 levels and neonatal outcomes in patients with gestational diabetes mellitus: a pilot study
Front Clin Diabetes Healthc. 2025 Oct 10;6:1682012. doi: 10.3389/fcdhc.2025.1682012. eCollection 2025. ABSTRACT INTRODUCTION: The prevalence of gestational diabetes mellitus (GDM)
PubMed
Rheumatoid Arthritis and Fibromyalgia Syndrome: A Bibliometric and Bioinformatics Perspective on Comorbidity Research
J Multidiscip Healthc. 2025 Oct 21;18:6811-6827. doi: 10.2147/JMDH.S547111. eCollection 2025. ABSTRACT OBJECTIVE: Rheumatoid arthritis (RA) and fibromyalgia syndrome (FMS) are
PubMed
Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging
J Hum Immun. 2025 Sep 1;1(3). doi: 10.70962/jhi.20250027. Epub 2025 Jul 30. ABSTRACT Germline gain-of-function (GOF) mutations in signal transducer
Google News
HSS Investigators Address the Impact of Social Determinants of Health and Perception of …
They made these presentations at ACR Convergence 2025, the annual meeting of the American College of Rheumatology, held in Chicago
Helio.com
AI identifies low disease activity in rheumatoid arthritis
CHICAGO — A machine learning model can use patient-reported data and remote therapeutic monitoring to accurately assess low disease activity
More Trial Details Reported for Novel Psoriasis Pill
(MedPage Today) — CHICAGO — Almost two-thirds of teens with plaque psoriasis saw complete skin clearance after 6 months of
Belimumab Before or After Immunosuppressant
Belimumab Before or After Immunosuppressant tammytilley@gm… Mon, 10/27/2025 – 15:13 Lupus Drug Safety Steroids Dr. Yuz Yusof reports on abstract
RheumNow
Primary CNS vasculitis: what else causes vessel wall enhancement on dedicated brain MRI? From Dr. Hajj-Ali https://t.co
Primary CNS vasculitis: what else causes vessel wall enhancement on dedicated brain MRI? From Dr. Hajj-Ali https://t.co https://pbs.twimg.com/profile_images/1684945388665442304/yPWpfGoX_normal.jpg john+RNV2@john… Mon,
RheumNow
At the Global Rheum Summit, patients called for care that values people, not just disease. ✅ Respect lived experience
At the Global Rheum Summit, patients called for care that values people, not just disease. ✅ Respect lived experience https://pbs.twimg.com/profile_images/1525262133575012354/Lfut18gD_normal.jpg
RheumNow
~1 in 6 pts with #sarcoidosis May have #cardiac involvemt 1/3 respond to #MTX + #steroids Followed by repeat #PET Fail
~1 in 6 pts with #sarcoidosis May have #cardiac involvemt 1/3 respond to #MTX + #steroids Followed by repeat #PET
RheumNow
In case you missed it in @ACR_Journals: HCQ for 1y does not prevent RA development in people with CCP3 >2x ULN, eithe
In case you missed it in @ACR_Journals: HCQ for 1y does not prevent RA development in people with CCP3 >2x
RheumNow
SELECT-COMPARE (upadacitinib vs adallimumab in mod-severe RA, no CV enrichment) 7y data: safety profiles very similar,
SELECT-COMPARE (upadacitinib vs adallimumab in mod-severe RA, no CV enrichment) 7y data: safety profiles very similar, https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg john+RNV2@john… Mon, 10/27/2025
RheumNow
#ACR25 Please find our Day 1 Recap of the conference where we discussed our favourite abstracts and learning points 😃
#ACR25 Please find our Day 1 Recap of the conference where we discussed our favourite abstracts and learning points 😃
RheumNow
Abstract 1421: PsA and ‘Brain Fog’ Pts w/ #PsA who did not achieve Minimal Disease Activity (MDA) had higher odds of su
Abstract 1421: PsA and ‘Brain Fog’ Pts w/ #PsA who did not achieve Minimal Disease Activity (MDA) had higher odds
RheumNow
In the IMPACT trial (Abs 0855), certolizumab met its primary endpoint: <20% had an adverse pregnancy outcome (APO) am
In the IMPACT trial (Abs 0855), certolizumab met its primary endpoint: <20% had an adverse pregnancy outcome (APO) am https://pbs.twimg.com/profile_images/1590198200824000512/8_JyVKFt_normal.jpg
RheumNow
Start strong, stay strong. With early anti-TNF induction (vs csDMARD T2T) – At 5 yrs: D2T RA in <1% vs 7% (OR 0.11,
Start strong, stay strong. With early anti-TNF induction (vs csDMARD T2T) – At 5 yrs: D2T RA in <1% vs